Malik Talha A
Department of Medicine-Gastroenterology, University of Alabama at Birmingham, 1808 7th Avenue South, BDB 391, Birmingham, AL 35294, USA; Department of Epidemiology, University of Alabama at Birmingham, 1808 7th Avenue South, BDB 391, Birmingham, AL 35294, USA.
Surg Clin North Am. 2015 Dec;95(6):1105-22, v. doi: 10.1016/j.suc.2015.07.006. Epub 2015 Sep 7.
Inflammatory bowel disease (IBD) describes a group of closely related yet heterogeneous predominantly intestinal disease processes that are a result of an uncontrolled immune mediated inflammatory response. It is estimated that approximately one and a half million persons in North America have IBD. Pathogenesis of IBD involves an uncontrolled immune mediated inflammatory response in genetically predisposed individuals to a still unknown environmental trigger that interacts with the intestinal flora. There continues to be an enormous amount of information emanating from epidemiological studies providing expanded insight into the occurrence, distribution, determinants, and mechanisms of inflammatory bowel disease.
炎症性肠病(IBD)是一组密切相关但异质性的主要累及肠道的疾病过程,是不受控制的免疫介导的炎症反应的结果。据估计,北美约有150万人患有炎症性肠病。炎症性肠病的发病机制涉及在遗传易感性个体中,对仍未知的与肠道菌群相互作用的环境触发因素产生不受控制的免疫介导的炎症反应。流行病学研究不断产生大量信息,为炎症性肠病的发生、分布、决定因素和机制提供了更深入的见解。